Castronovo F P, McKusick K A, Strauss H W
Department of Radiology, Massachusetts General Hospital, Boston.
Invest Radiol. 1994 Jan;29(1):59-64. doi: 10.1097/00004424-199401000-00010.
Little is known about the time-related biologic behavior of radiopharmaceutical misinjections. Such inadvertent tissue infiltration of such injections may not only adversely affect a scheduled test or cause some discomfort, but potentially could produce tissue damage. Radiopharmaceutical infiltrations were assessed in a rat model.
Particulate and nonparticulate radiopharmaceuticals were injected subcutaneously or intradermally into an anesthetized shaved rat model. The rate of release of the nine infiltrations per radiopharmaceutical per injection type were measured from computer data acquired with a gamma camera up to 24 hours after administration. These data were used for dosimetry determinations.
When injected subcutaneously, the particulate radiopharmaceutical, technetium 99m (99mTc) albumin microspheres, exhibited essentially no movement, and the soluble agents showed a biexponential release pattern. The rate of release was similar for 99mTc methylene diphosphonate (99mTc MDP) and for 67Ga citrate (67Ga), whereas thallous chloride (201Tl) exhibited the slowest release pattern. The average effective half-lives (T1/2 av-eff) were 78.3 minutes, 76.1 minutes, and 268.4 minutes, respectively. When injected intradermally, the nonparticulates exhibited a triexponential release pattern; MDP showed a more rapid release (T1/2 av-eff, 50 minutes) and 201Tl showed the slowest (T1/2 av-eff, 491.2 minutes). Absorbed doses were calculated using conventional medical internal radiation dose (MIRD) methodology for small unit density spheres. The absorbed dose was greatest for a 201Tl infiltration. A 201Tl infiltrate of 1 mCi per gm of tissue is capable of producing radiation-absorbed doses greater than 500 rads. Additional studies were performed with heat, hyaluronidase, and volume dilution in an attempt to accelerate the rate of release of 201Tl. Local heat application proved to be more efficient than volume change or hyaluronidase application.
These data indicate an insignificant skin radiation burden from the majority of nonparticulate infiltrated radiodiagnostic agents. Thallium 201, however, has the potential to produce significant radiation burdens when infiltrated at high specific activity. Actual human infiltration release rates may differ because of variants in blood flow and assumed infiltration volume relative to the animal model.
关于放射性药物误注射的时间相关生物学行为知之甚少。此类注射意外渗入组织不仅可能对预定检查产生不利影响或引起一些不适,还可能导致组织损伤。在大鼠模型中评估了放射性药物的渗入情况。
将颗粒状和非颗粒状放射性药物皮下或皮内注射到麻醉去毛的大鼠模型中。在给药后长达24小时内,通过γ相机采集的计算机数据测量每种放射性药物每种注射类型的9次渗入的释放速率。这些数据用于剂量测定。
皮下注射时,颗粒状放射性药物99m锝(99mTc)白蛋白微球基本没有移动,而可溶性药物呈现双指数释放模式。99mTc亚甲基二膦酸盐(99mTc MDP)和枸橼酸镓(67Ga)的释放速率相似,而氯化铊(201Tl)的释放模式最慢。平均有效半衰期(T1/2 av-eff)分别为78.3分钟、76.1分钟和268.4分钟。皮内注射时,非颗粒状药物呈现三指数释放模式;MDP释放较快(T1/2 av-eff,50分钟),201Tl释放最慢(T1/2 av-eff,491.2分钟)。使用传统的医学内照射剂量(MIRD)方法计算小单位密度球体的吸收剂量。201Tl渗入的吸收剂量最大。每克组织1毫居里的201Tl渗入能够产生大于500拉德的辐射吸收剂量。还进行了加热、透明质酸酶和体积稀释的额外研究,试图加速201Tl的释放速率。局部加热被证明比体积变化或使用透明质酸酶更有效。
这些数据表明,大多数非颗粒状渗入的放射性诊断剂对皮肤的辐射负担微不足道。然而,201Tl在高比活度渗入时有可能产生显著的辐射负担。由于血流变化以及相对于动物模型假定的渗入体积,实际人体渗入释放速率可能不同。